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ABSTRACT
Sleep comprises approximately one-third of a person’s lifetime, but its impact on health and medical conditions re-
mains partially unrecognized. The prevalence of sleep disorders is increasing in modern societies, with significant
repercussions on people’s well-being. This article reviews past and current literature on the paradoxical sleep de-
privation method as well as data on its consequences to animals, ranging from behavioral changes to alterations
in the gene expression. More specifically, we highlight relevant experimental studies and our group’s contribution
over the last three decades.
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INTRODUCTION
Sleep occupies approximately one-third of a person’s
life, but its impact on health and medical conditions re-
mains partially unrecognized. The prevalence of sleep
disorders is increasing in modern societies, where con-
stant exposure to artificial light and interactive activities,
such as television and the internet, combine with social
and economic pressures to shorten the time spent asleep.
Most sleep disorders, such as sleep apnea, periodic
leg movements disturbance, restless legs syndrome, jet
lag, and insomnia, lead to sleep deprivation. Sleep de-
privation per se represents a common type of stress that
can have harmful physiological consequences, possibly
leading to death in experimental animals (Rechtschaf-
fen et al. 1983). Chronic insomnia leads to persistent
tiredness and frustration due to lack of energy. Respi-
ratory pathological conditions and other medical condi-
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tions that affect sleep have potentially serious complica-
tions that may reduce life expectancy.
Disturbances in the sleep-wake rhythm and sleep
deprivation are increasingly frequent due to events that
are progressively more common in modern life in more
developed countries (Spiegel et al. 1999). Many sub-
jects can be chronically sleep-deprived as a result of
their current lifestyle (Miró et al. 2002). Sleep depriva-
tion can lead to traffic accidents due to fatigue and alter-
ations in the biological rhythm. Indeed, 16% of Brazil-
ian interstate bus drivers reported sleepiness while driv-
ing, with an average of eight naps/trip (De Mello et al.
2000), and 38% of those drivers have been diagnosed
with obstructive sleep apnea (Santos et al. 2004). Re-
cently, a new legislation was approved that will require
new medical and psychological examinations for all
Brazilian drivers. These examinations will be initially
carried out by a physician who specializes in traffic me-
dicine. As a result, it can be expected a reduction in the
number of accidents and deaths resulting from sleepy
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driving (De Mello et al. 2009). An epidemiological
study performed by the Department of Psychobiology
of Unifesp in the city of São Paulo has shown that, in
1995, 27.6% (1.7 million) of inhabitants of São Paulo
complained of difficulty in staying asleep. Furthermore,
habitual snoring was the most common complaint and
was reported by about 20% of the interviewees (Pires et
al. 2007). In 2007, obstructive sleep apnea syndrome
was found in 32.8% of the population of São Paulo,
Brazil (S. Tufik et al., unpublished data).
Sleep has a cyclical or episodic phase that alter-
nates with wakefulness. An important characteristic of
sleep that differentiates it from most of other states of
altered consciousness is that it is promptly reversible.
Electrophysiological studies in the 1950s demon-
strated that there are two main states of sleep: non-rapid
eye movement (NREM) and rapid eye movement (REM).
The lighter stages of NREM sleep (phase 1 and 2) appear
first and often alternate with brief episodes of wakeful-
ness before the deeper NREM sleep stages set in. NREM
sleep, particularly its deeper stages (phase 3 and 4), pre-
dominate early in the night, while REM sleep occurs at
approximately 90-minute intervals. There are usually
four to six sleep cycles each night, and, as the night pro-
gresses, the REM episodes become longer, and NREM
episodes become both shorter and lighter. NREM sleep
is recognized by its low frequency and high amplitude, in
addition to the presence of sleep spindles and hypotonia
as registered on an electroencephalogram (EEG).
Research suggests that REM sleep enables the
establishment of behavior patterns and emotional re-
sponses. During REM sleep, the information obtained
during wakefulness appears to be reprocessed and in-
tegrated into existing neural templates, so that future
responses can be modified or matured to reflect both
the experience of the individual and the inherent poten-
tial (Jouvet 1998). The electrophysiological features of
REM sleep include recording of a wide range of de-
synchronized EEG frequencies, loss of EMG activity
and rapid eye movement. The EEG reflects the intense
cerebral cortical activity that distinguishes REM from
NREM sleep, but the similarity of REM to the EEG of
wakefulness has led it to be called “paradoxical” sleep
(PS). This term has been adopted for the description of
animals in this review.
A common irregular sleep-wake schedule is as fol-
lows: restricting sleep during a working week, leading
to an accrual of sleep debt, and repaying the debt by
sleeping longer on weekends. During these nights, there
is high sleep efficiency, short sleep latency, and in-
creased duration of stages 3 and 4 NREM sleep. Waking
later in the morning, however, causes a phase delay the
next day, which is often followed by an early wake-up
time at the start of the working week. The duration of
sleep is thereby considerably shortened, and sleep depri-
vation begins again (Shneerson 2000).
The homeostatic sleep drive appears to control
NREM rather than REM sleep. Sleep is normally en-
tered through NREM rather than REM sleep in adults,
and an increase in the homeostatic drive will increase
the duration and depth of NREM sleep at the expense of
REM sleep. NREM sleep provides time for restorative
processes within the central nervous system (CNS) and
other parts of the body. Overall, NREM sleep appears
to be a phase in which energy is conserved and in which
both the CNS and other systems are able to either recover
from the activity of the previous episode of wakefulness
or to prepare for the next episode. Currently, most sleep
deprivation occurs in the REM phase, which occurs dur-
ing the last half of the total sleep session. It is in this
phase that most restorative processes take place.
There are several different approaches that may
be taken to understand the functional properties of PS.
A common procedure involves deprivation of PS in var-
ious organisms and subsequent observation of behav-
ioral and physiological changes. Thus, most studies of
sleep deprivation focus on PS deprivation (PSD). The
present paper reviews various studies that have utilized
the PSD strategy.
PSD METHODS
The PSD technique entails an arousal of experimental
animals by external stimulation at the onset of each PS
period. Most of the instrumental methods utilized to in-
duce PSD in animals are modifications of a single method
developed by Jouvet et al. (1964) for cats, known as the
flower pot technique. Shortly afterward, this method
was adapted to rats by Cohen and Dement (1965). The
method consists of placing a rat on a narrow platform
(6.5 cm in diameter) surrounded by water. Once ha-
An Acad Bras Cienc (2009) 81 (3)
“main” — 2009/7/27 — 14:50 — page 523 — #3
SLEEP DEPRIVATION IN ANIMALS 523
bituated to this situation, the animals can obtain slow
wave sleep (SWS), whereas PS is restricted. The loss
of muscle tone associated with the onset of PS results
in the animals touching the water and awakening. In-
formation regarding the efficiency of the technique in-
dicates that the degree of PSD may vary considerably.
The diameter of the platform relative to the size of the
animal seems to be mainly responsible for this variabil-
ity (Steiner and Ellman 1972, Mendelson et al. 1974,
Hicks et al. 1977). This method has been criticized
because it submits the animal to additional adverse stim-
uli that could induce several of the effects observed
after PSD.
To attenuate the effects of these intervening vari-
ables, the multiple platform method was developed. In
this paradigm, one rat is placed inside a large water tank
containing seven platforms, which eliminates the res-
triction of movement and allows the animal to ambulate
(Van Hulzen and Coenen 1981). This method was fur-
ther modified in an attempt to eliminate the social iso-
lation experienced by the animal in both the flower
pot and the multiple platform techniques (Nunes and
Tufik 1994a). In this paradigm, 10 animals on 18 nar-
row or wide platforms (as a control for the deprivation
environment) are used, thus avoiding both social isola-
tion and movement restriction. This technique is pro-
cedurally simple and allows for a large number of an-
imals to be sleep deprived simultaneously. In 2000,
Suchecki and Tufik proposed the modified multiple plat-
form method (MMPM) using socially stable groups (10
animals from one cage) instead of animals coming from
several cages. The results of this work suggest that the
stress-related variables of the MMPM can be attenuated
in stable groups.
Regarding the control group, most attention has
been focused upon the selection of control subjects.
When an animal is placed on a small platform in the
water tank, many events happen in addition to PSD. For
example, the animal is exposed to a good deal of stress.
Control groups usually consist of either cage-control an-
imals or rats placed on a wide platform (14 cm in di-
ameter) under the same environmental conditions. This
large platform enables the animal to curl up and expe-
rience both SWS and PS without contacting the water.
It is commonly used as a control for the confounding
factors inherent to this technique. Although this control
may be appropriate to address most of the confounding
factors, it remains controversial (Landis 1996, Machado
et al. 2004). Indeed, when exposed to the MMPM,
the animals placed on the wide platforms exhibit adrenal
hypertrophy similar to that produced by placement
on narrow platforms (Nunes and Tufik 1994a). In addi-
tion, a wide platform induces some degree of PSD,
as reflected by augmented rebound during the recov-
ery period (Machado et al. 2004). In the rotation disk
method proposed by Rechtschaffen et al. (1983), non-
specific concomitants of this technique are controlled
by a “yoked” control animal, which is concurrently
aroused with the experimental animal (Van Hulzen and
Coenen 1979). In the disk method, whenever the ex-
perimental rat begins to sleep or enters a specific sleep
stage, the disk automatically rotates, which awakens the
experimental rat and forces both rats to walk in the op-
posite direction to the disk’s rotation to avoid the wa-
ter (Rechtschaffen et al. 1983). Another proposed con-
trol group for the deprivation environment consisted of
animals lying on a grid placed inside the water tank
(Suchecki and Tufik 2000). In this situation, the animals
could lie down without falling into the water, although
their tails might have done so. The data suggest that this
is a good control; however, sleep rebound was observed.
The animal is exposed to a similar environment without,
in theory, being submitted to PSD. It is important to note
that only social stable animals were placed on the grid,
as described in the same paper.
Recently, we proposed a paradigm for chronic sleep
restriction in rats in which the animals are submitted to
a schedule of 18h of sleep deprivation with a 6h sleep
window for 21 days (Machado et al. 2005). As a result
of this restriction, there was a complete suppression of
PS and loss of SWS, which were partially compensated
during the 6h sleep window. Of note, a major sleep con-
solidation was observed during the 6h sleep opportunity,
reflected by an intense reduction of awakenings.
REBOUND SLEEP
The importance of PS to an organism can be partly de-
duced from recovery sleep after deprivation. PSD in-
variably leads to a striking compensation phenomenon,
known as the PS rebound. According to Van Luijtelaar
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and Coenen (1984), rebound sleep is determined both
by recovery processes and circadian timing. The in-
creases (above baseline) in sleep duration during the re-
covery from sleep deprivation are usually only a fraction
of the sleep time that was lost. Because it is widely
assumed that sleep is homeostatically regulated, many
believe that lost sleep is compensated by “intense
sleep” that satisfies the unfulfilled sleep need in a rela-
tively short period (Rechtschaffen et al. 1999). In ad-
dition to an increased sleep duration, the latency to the
first PS episode is shortened, and the time spent in PS
is lengthened (Dement 1960, Mendelson et al. 1974,
Morden et al. 1967). Sleep rebound is also observed
in rats submitted to different stress modalities (Tufik et
al. 1995, Palma et al. 2000, Papale et al. 2005). For
instance, immobilization led to a rebound of SWS and
PS, whereas cold stress produced an exclusive rebound
of SWS and foot shock promoted sustained alertness
during the animal’s resting period. Together, these ob-
servations indicate that different stimuli alter the sleep
pattern in distinct manners (Palma et al. 2000).
EFFECTS OF PSD ON BRAIN NEUROTRANSMITTERS
The nature of PSD techniques has led to much discus-
sion about its consequences (Vogel 1975, Ellman et al.
1978). Most of the consequences are believed to be
controlled by central neurotransmitter systems. To that
end, many neurotransmitters, such as catecholamines,
acetylcholine, serotonin, and GABA, have been associ-
ated, either alone or in trans-synaptic relationships, with
several behavioral alterations. These associations sug-
gest that the behavioral alterations observed after PSD
result from deprivation-induced alterations in brain
neurotransmitter function.
Evaluation of experiments that employed the water
tank PSD technique indicated that this procedure alters
some behaviors that can be induced by drugs that act on
neurotransmitter systems. The neurochemical basis of
the constellation of behavioral changes that follow PSD
is not completely clear, but many observations suggest a
major role for central dopamine (DA).
In 1978, Tufik and colleagues reported that PSD
resulted in augmented apomorphine-induced aggression
and several stereotypical behaviors, including biting,
rearing and hypothermia in rats. These behaviors oc-
curred with greater magnitude and with smaller doses
of apomorphine in the PSD rats when compared with
control animals, and have been used to study the respon-
siveness of DA receptors to agonist agents. The authors
suggested that the findings led to the belief that PSD
induced supersensitivity of brain DA receptors. Shortly
thereafter, further experiments supported the hypothesis
that the exacerbated aggressiveness elicited by apomor-
phine in PSD rats was due to a state of supersensitiv-
ity of post-synaptic dopaminergic receptors in the brain
(Tufik 1981a). This study showed that, in addition to
apomorphine, PSD intensified the effects of two other
dopaminergic agonists (bromocriptine and piribedil).
The second finding of this study was that co-adminis-
tration of PSD and an injection of haloperidol 24h be-
fore apomorphine administration induced more aggres-
sive behavior when compared to that of rats that were
only subjected to PSD, indicating that apomorphine was
significantly more active in rats submitted to the dou-
ble treatment. Finally, administration of haloperidol 2h
before apomorphine administration blocked the aggres-
sive behavior in rats submitted either to PSD alone or
to PSD and an injection of haloperidol 24h previously.
This result further supports the hypothesis that the post-
synaptic dopaminergic receptors are in a state of super-
sensitivity.
Alternatively, these data may indicate that pre-
synaptic dopaminergic activity was augmented by the
above-described treatment regimen. Ghosh et al. (1976)
reported that striatal DA levels were increased after
PSD, raising the hypothesis that the hyperresponsive-
ness to apomorphine after PSD could merely reflect an
excess of agonistic substances at the post-synaptic re-
ceptors. Tufik (1981b) reported that such a response was
not due to a modification in DA turnover or levels, since
it was demonstrated that animals treated with L-DOPA
and injected with apomorphine failed to show aggressive
behavior. However, PSD rats pre-treated with α-methyl-
para-tyrosine continued to show an intense response to
DA agonists, suggesting that presynaptic mechanisms
are not of prime importance for this augmented PSD-
induced response (Tufik 1981b). In a later study, it was
shown that the increase in apomorphine-induced stereo-
typy and aggression in PSD rats was reversed by DA
agonist pretreatment (Troncone et al. 1988).
An Acad Bras Cienc (2009) 81 (3)
“main” — 2009/7/27 — 14:50 — page 525 — #5
SLEEP DEPRIVATION IN ANIMALS 525
Interaction between the DA and norepinephrine
(NOR) systems, which was achieved through modula-
tion of the DA drug regimen, induced aggressive be-
havior in PSD rats that were pretreated with adrenergic
drugs. This result indicates that NOR had a slight in-
hibitory action on the aggressiveness elicited by dopa-
minomimetic agents in PSD rats (Troncone and Tufik
1991). The reduced level of aggression could be due to
a small increase in DA release associated with a lack of
secondary noradrenergic inhibition rather than to a lack
of NOR activity. This situation would evidence a role
for beta-adrenoceptors in the modulation of this behav-
ior. This proposition is supported by the observation that
a reduced number of β-adrenoceptors are present in the
cortex of rats submitted to PSD (Mogilnicka et al. 1986).
This tissue has been shown to be subsensitive to NOR,
which is reflected by evaluation of in vitro cyclic-AMP
synthesis (Troncone et al. 1986). Autoradiographic anal-
ysis shows a generalized but regionally heterogeneous
reduction in the number of β receptors subtypes in the
brain, as well as clear trends of down- and up-regulation
of α1 and α2 sites, respectively (Hipólide et al. 1998).In another set of experiments that evaluated PSD
and DA, yawning behavior was used to assess the sensi-
tivity of DA and acetylcholine receptors in rats submit-
ted to PSD (Tufik et al. 1987). The results demonstrated
that PSD significantly decreased the yawning response
induced by presynaptic doses of apomorphine and small
doses of physostigmine and pilocarpine, suggesting that
PSD induces subsensitivity of presynaptic DA receptors
and/or postsynaptic acetylcholine receptors.
A large body of evidence indicates that drug-in-
duced yawning in rats is a behavioral consequence of
dopaminergic autoreceptor stimulation, which results in
decreased DA synthesis and release, impaired dopamin-
ergic transmission, and consequent removal of the in-
hibition of cholinergic neurons exerted by DA neurons
(Yamada and Furukawa 1981). Thus, yawning behav-
ior seems to involve both dopaminergic inhibition and
cholinergic activation. By evaluating animals after a re-
covery period of 24h, Neumann et al. (1990) observed
that, while apomorphine-induced yawning was still sig-
nificantly reduced, pilocarpine-induced yawning had re-
turned to normal, suggesting that PSD alters these sys-
tems differently. It seems that interference on the dopa-
minergic system occurs more strongly and at an earlier
time than on cholinergic system.
With respect to the evidence mentioned above,
these findings led to the hypothesis that PSD induces
an upregulation of dopaminergic receptors (Tufik et al.
1978, 1987). However, because apomorphine is a mixed
D1/D2 agonist, it was not possible to determine fromthose experiments which subtype of dopaminergic re-
ceptor is unregulated after PSD. Nunes et al. (1994b)
used autoradiographic analysis to address this question.
They found that PSD increased D2 but not D1 recep-tor binding in the brain, suggesting that the unregulated
D2 receptors are responsible for the previously reportedchanges in apomorphine-induced behaviors after PSD.
An increase in DA release in the PSD group exerts
greater dopaminergic-mediated effects due to upregula-
tion of DA receptors in the striatum of PSD rats com-
pared to control group (Farooqui et al. 1996). This find-
ing further supports the early studies on behavioral
effects of dopaminergic stimulants in PSD animals (Tu-
fik et al. 1978, Clark et al. 1987, Asakura et al. 1992).
However, the decrease in yawning behavior induced by
cholinergic agonists (Tufik et al. 1987) led to an inves-
tigation of cholinergic receptors in animals submitted
to PSD. Again, an autoradiographic study showed that
PSD resulted in a generalized down regulation of M2-type muscarinic receptors in the brain of a rat, corrob-
orating the notion that pontine M2-type receptors mayparticipate, but do not necessarily play an integral role,
in the development of PSD effects (Nunes et al. 1994c).
Some evidence suggests that PSD enhances sero-
tonergic transmission. Bearing this in mind, direct ex-
amination of 5-HT receptor binding after PSD was re-
stricted to early studies that used a non-selective ligand
[3H]5-HT in a limited number of brain areas. These
studies showed that binding to 5-HT1a was not signifi-cantly altered by PSD in any of the brain areas exam-
ined. However, there was an overall trend toward de-
creased binding in the target paradoxically sleep deprived
group. The same phenomenon occurred with serotonin
transporter (SERT) binding after PSD. The frequency of
ligand binding to 5HT2 sites was generally decreased af-ter PSD in 81 brain areas, and this reduction was more
pronounced in the sleep recovery period (Hipólide et
al. 2005).
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Orexins are a newly discovered class of neuro-
peptides that regulate feeding and vigilance. Initially
recognized for their importance in appetite control,
orexins (also called hypocretins) are also involved in
regulating sleep, arousal, and cardiovascular function.
Loss of orexin appears to be the primary cause of nar-
colepsy (Kilduff and Peyron 2000, Sutcliffe and de
Lecea 2002). Expression of orexins is restricted to a
discrete region of the hypothalamus, but the terminal
projections of orexin-producing cells are widely distrib-
uted throughout the brain. In the rat, orexin induces a
dose-dependent increase in wakefulness when it is
injected intracerebroventricularly (Piper et al. 2000).
The densest projection of orexinergic cells in the rat is
in the locus coeruleus (Horvath et al. 1999), the nora-
drenergic output that favors cortical arousal of waking
and opposes PS-associated arousal (Hobson et al. 2000,
Aston-Jones et al. 2001).
Pedrazzoli et al. (2004) measured hypocretin lev-
els at 6 and 96h after PSD and following 24h of re-
bound. PSD was found to increase cerebral spinal fluid
orexin-1 collected at zeitgeber time (ZT) 8, but not at
ZT0. Decreased cerebral spinal fluid orexin levels were
also observed at ZT8 after 24h of PS rebound. These
results suggest that PSD activates and that rebound in-
hibits the orexin system. The authors suggested that
increased orexin tone during PSD might be important
for some of the effects of PSD, such as antidepressant
effects, hyperphagia, and increased sympathetic activ-
ity. Another experiment performed by D’Almeida et
al. (2005) showed that the level of prepro-orexin (the
precursor of both forms of orexin) mRNA increased by
30% at 96 hours after in the PSD group and by 88%
after 24 hours in the rebound group relative to controls.
Sleep deprivation produced a heterogeneous effect on
brain mRNA levels of both orexin receptors (OXR).
The OX1R mRNA levels increased in more than 30 dif-ferent regions, particularly in the amygdala and hypo-
thalamus in the rebound group compared to control and
sleep deprived groups. Changes in OX2R mRNA lev-els were also seen only in the sleep rebound group, but
the levels were decreased rather than increased, and they
were predominantly confined to the cerebral cortex.
These observations suggest that continued sleep depriva-
tion progressively increases prepro-orexin mRNA levels
and alters orexin receptor expression. These effects are
not immediately reversed by sleep recovery, indicating a
lasting activation of the orexinergic system. Collectively,
the overall changes in brain neurotransmitters after PSD
may indicate that the mechanisms involve in the process
of sleep recovery.
PSD AND GENE EXPRESSION
Sleep deprivation of short duration or prolonged for
several days alters the expression of distinct categories
of genes in the brain, including immediate-early genes,
such as transcription factors; genes that encode proteins
involved in metabolic processes, neuronal plasticity,
and the stress response; and genes that encode neuro-
transmitters, hormone receptors and transporters, and
enzymes (Cirelli et al. 2004, Cirelli 2006, Terao et al.
2008, Maret et al. 2007). In addition, it has been shown
that the pattern of changes is consistent across species
(Cirelli 2002) and in distinct brain regions (Cirelli et
al. 2004, Terao et al. 2008).
Through the use of microarrays to evaluate the
expression of > 30, 000 transcripts, we recently iden-
tified a total of 78 unique transcripts that were differ-
entially expressed in animals submitted to PSD rela-
tive to controls (Guindalini et al. 2009). These differ-
entially expressed transcripts include genes from many
functional classes, including metabolic processes, the
circadian sleep-wake cycle, the response to a stimulus,
regulation of cell proliferation, and signaling pathways.
After 24h of sleep rebound, expression of ∼ 61.5% of
the sleep deprivation-regulated transcripts was detected
as being differentially expressed in the recovery period,
resembling the gene expression pattern of the controls,
relative to the PSD group. However, as occurs with
a number of behavioral and physiological parameters,
the expression levels of the remaining 38.5% of tran-
scripts were among the levels observed for control and
sleep-deprived animals, suggesting that a longer recov-
ery period is necessary to completely reverse the ef-
fects of prolonged PSD. Noteworthy, DNA damage is
an important step in events leading to genomic instabil-
ity. We recently conducted an experiment demonstrat-
ing that DNA damage was preferentially induced in the
brain and blood cells of paradoxically sleep deprived
rats, whereas no detectable changes were observed in
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the liver or heart cells (Andersen et al. 2009). This study
represents a relevant contribution to the understanding
of the potential health risks associated with sleep depri-
vation. Collectively, these results suggest that PSD elic-
its a pattern of gene expression that is similar to those
observed for other paradigms of sleep deprivation, and
that PSD has characteristics that might be related to the
regulation of PS. In addition, 24h of sleep recovery was
not sufficient for complete reversal of the effects caused
by prolonged periods of PSD of a number of behavioral
and physiological parameters (Andersen et al. 2005a,
Antunes et al. 2006).
Interestingly, Maret and colleagues demonstrated
that sleep deprivation induced a larger number of tran-
scriptional changes in the liver than in the brain, sug-
gesting that sleep deprivation might have a strong effect
on peripheral tissues and/or that the brain might be pro-
tected from major changes in transcription (Maret et al.
2007). This study corroborates our results, which indi-
cate that there is less variation in the gene expression in
the brain compared to other tissues, such as blood and
cavernosum, following PSD (Lee et al. 2009).
PSD AND BEHAVIORAL ALTERATIONS
YAWNING
Apart from the constellation of behavioral and neuro-
pharmacological consequences of PSD, yawning is par-
ticularly interesting because it can be elicited by sev-
eral cholinergic agonists (Urbá-Holmgren et al. 1977,
Wood et al. 1979), such as low doses of dopaminergic
agonists (Mogilnicka and Klimek 1977) and polypep-
tides such as α-MSH and ACTH (Ferrari et al. 1963,
Yamada and Furukawa 1981, Lobo et al. 1990). This
finding suggests that multiple neurotransmitter systems
modulate this behavior. PSD for 96h results in nearly
complete suppression of yawning induced by dopamin-
ergic and cholinergic agonists (Tufik et al. 1987). Since
the activity of both of these neurotransmitter systems
is also altered by stress (De Kloet 1991), animals were
chronically exposed to different stress modalities. The
evaluation of yawning induced by dopaminergic and
cholinergic drugs showed that immobilization caused
suppression of this behavior, whereas forced swimming
and foot shock increased the number of yawns. These
findings suggest that yawning is differentially altered
by constant and intermittent stressors (Tufik et al. 1995).
As these stressful manipulations altered drug-in-
duced yawning, Hipólide et al. (1999) investigated the
effects of single and repeated treatments with a syn-
thetic glucocorticoid, dexamethasone (DEXA) on apo-
morphine- and pilocarpine-induced yawning in rats.
Neither single nor repeated treatment with DEXA al-
tered apomorphine-induced yawning. A single injec-
tion of DEXA, however, caused an increased number
of yawns induced by pilocarpine. Repeated treatment
with DEXA led to a decreased number of yawns in-
duced by pilocarpine. The authors concluded that dopa-
minergic and cholinergic systems are distinctly altered
by DEXA in terms of yawning behavior. Furthermore,
yawning behavior was evaluated to examine whether
concomitant treatment with PSD and DA agonists could
reverse PSD effects (Lobo et al. 1995), as observed with
stereotypy and aggressiveness (Troncone et al. 1988).
More recently, the effects of acute and chronic 18-
and 19-tetrahydrocannabinol (18 and 19-THC) were
examined on yawning induced by pilocarpine or apo-
morphine. The data suggest that cannabinoid agonists
inhibited yawning induced by cholinergic and dopamin-
ergic agonists. In addition, the increased frequency of
spontaneous yawning following cessation of chronic ad-
ministration of a cannabinoid agonist may be of impor-
tance as a withdrawal sign for these drugs (Nakamura-
Palacios et al. 2002). Cannabis also induces aggressive
behavior in PSD rats. This effect is probably related to
brain catecholamines, as DA may play an agonist role
and NOR an inhibitory role (Carlini et al. 1977).
COGNITION
Sleep has roles in learning and memory processes at
several levels (Stickgold and Walker 2007). Two main
lines of evidence support this hypothesis in rodents.
Firstly, PS following the acquisition of learning tasks
leads to increases in the number and duration of epis-
odes and PS density (Smith and Wong 1991). Secondly,
many studies report an impaired acquisition when PSD
is performed before or after the training period for sev-
eral learning tasks (Smith 1985, Silva et al. 2004a, b).
PSD performed before the training period resulted in
acquisition deficits that were not task-specific. This is
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because the procedure affected inhibitory avoidance and
an appetite-motivated task (Stern 1971). In contrast, us-
ing appetitive motivation, no effect on accuracy of T-
maze discrimination was found with PSD (Hicks and
Paulus 1973). The nature of the task might be one fac-
tor that accounts for these discrepancies. To determine
whether PSD administered prior to training would have
differential effects on two aversively motivated tasks
(classical conditioning of fear and inhibitory avoidance),
Bueno et al. (1994) submitted rats to PSD, and the rats
were trained on a double aversively motivated task. The
data show that PSD administered 24 or 72h before the
training session had no effect on either task. However,
when the period of deprivation was extended to 96h
before the training session, acquisition of inhibitory
avoidance was impaired, but no effect on classically
conditioned fear was observed. Thus, the authors con-
cluded that PSD had differential effects on the two
tasks, both aversively motivated and trained at the same
time and under the same conditions. Moreover, the
study on the effects of pharmacological interference
with the cholinergic system on PSD-induced memory
impairment show that activation of this system during
the period of deprivation can prevent memory deficits
induced by PSD (Bueno et al. 2000). Later data from
our group suggest that proactive learning/memory
deficits induced by PSD could be attributed to altered
M1 binding either immediately after PSD (when avoid-
ance training occurs) or after sleep recovery (when
acquisition/retention are tested) (Moreira et al. 2003).
In 2000, Silva and Frussa-Filho proposed the use
of the plus-maze discriminative avoidance task (PM-
DAT), which is a behavioral paradigm that has the ad-
vantage of independently evaluate learning, memory,
and anxiety as well as motor activity. PM-DAT com-
plies with ethical protocols since there is no foot shock,
which is imposed by classical avoidance tests. Consid-
ering the effects of PSD in mice submitted to the PM-
DAT (Silva et al. 2004b), pre-training PSD-induced anx-
iogenic and hypolocomotor effects were observed in the
training session, but they did not modify the acquisi-
tion of the task.
Recently, Alvarenga et al. (2008) investigate the
effects of PSD for 96h on the learning/memory pro-
cesses in rats submitted to the PM-DAT, which simulta-
neously evaluates learning, memory, anxiety and motor
function. Our results demonstrate that PSD induced im-
pairment in the acquisition, consolidation and retrieval
of a discriminative avoidance task. In the three experi-
mental conditions, a 24h sleep recovery period was ef-
fective in abolishing the PSD cognitive effects, but was
ineffective in modifying them per se. In addition, PSD
produced significant alterations in anxiety-like behav-
ior and locomotor activity, which may be related to the
impairment in retrieval (but not in acquisition or con-
solidation). This study strengthened the critical role of
PS (but not sleep rebound) in all the phases of learn-
ing and memory formation. In addition, it suggests that
PSD effects on acquisition and consolidation do not
seem to be related to other behavioral alterations in-
duced by this procedure.
LOCOMOTOR AND ANXIETY-LIKE BEHAVIOR
Regarding the effect of PSD on locomotor activity
(Tufik and Silveira-Filho 1983, Frussa-Filho et al. 2004,
Andersen et al. 2005b, Perry et al. 2007), some studies
have focused on locomotor activity and sleep patterns.
Consequently, speculations about the effect of the exer-
cise on sleep due to sleep deprivation have been raised
(Martins et al. 2001).
From our data, it can be assumed that PSD induced
significant but heterogeneous effects in animals. For in-
stance, PSD increased grooming, but it had no effect on
stereotyped behaviors, locomotion, or the elevated plus
maze test. Importantly, it significantly decreased rear-
ing behavior, which is associated with potentiation of
stereotypy and exploratory activity (Andersen et al.
2005b). In addition, another study showed that single
platform PSD rats had reduced locomotor activity and
augmented anxiety-like behavior (Suchecki et al. 2002).
Recently, Martins and colleagues (2008) pointed out that
PSD increased gnawing behavior undirected to feeding,
supporting the view that spontaneous oral stereotypy,
rather than hunger, is the major cause of increases in
food removed from feeders in rats deprived of sleep for
up to 96 hours.
In mice, sleep deprivation for 72h, achieved by the
multiple platform method, induces increased anxiety as
evaluated by the PM-DAT and in the conventional plus-
maze (decreased time spent in the open arms) (Silva et
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al. 2004a, b), as well as in the open-field test (decreased
in central locomotion frequency). This anxiogenic effect
was not observed after 24h of sleep deprivation.
SEXUAL BEHAVIOR
As mentioned, PSD results in several behavioral alter-
ations in rats that are likewise induced by dopaminergic
agonists (Tufik et al. 1978, 1987, Andersen and Tufik
2005); however, there is some controversy about the ef-
fect of PSD on sexual behavior. DA plays a key role in
the modulation of this behavior (Bitran and Hull 1987).
Morden and co-workers (1968) reported increased sex-
ual performance in PSD male rats. In another study,
however, four days of PSD did not significantly alter
male sexual performance (Hicks et al. 1991).
In this context, we have consistently demonstrated
the facilitatory effects of PSD on genital reflexes (penile
erection, or PE, and ejaculation, or EJ) in rats (Ander-
sen et al. 2000). The data revealed that only PSD rats
exhibited PE and EJ behaviors, which were absent in
control animals. Indeed, combined administration of
PSD and cocaine elicited genital reflexes much more
markedly than did administration of PSD or cocaine
alone (Andersen and Tufik 2002). Although a number of
factors are involved in a complex phenomenon such as
PE, the authors suggest that the previously documented
DA receptor supersensitivity induced by PSD may be an
important contributor to the potentiation of genital re-
flexes by cocaine after sleep deprivation. Importantly,
other dopaminergic drugs, such as cocaine (Andersen et
al. 2004a, b), methamphetamine (Andersen et al. 2003a)
and apomorphine (Andersen et al. 2003b), also increased
the effects of PSD on genital reflexes in both young
(Andersen et al. 2003c) and old male rats (Andersen et
al. 2002, 2004a).
The period of exposure to PSD seems to inter-
fere with the responses of genital reflexes. After 24h
of PSD followed by cocaine administration, adult an-
imals started to display PE and EJ, which peaked at
96h of PSD. More than 96h of PSD decreased genital
reflexes, as observed at 120 and 144 hours (Andersen et
al. 2003d).
Interestingly, hormone levels seem to play a criti-
cal role in these erectile events (for review, see Ander-
sen and Tufik 2006, 2008). Indeed, PSD decreases the
level of testosterone, whereas progesterone levels were
increased in both young and old groups, suggesting that,
although sexual function commonly decreases with age,
testosterone alone cannot be considered the main hor-
mone involved in sexual activity (Andersen et al. 2002,
2003c, 2004a, b).
ESTROUS CYCLE
Thus far, little attention has been given to whether sleep
is differentially regulated between genders and the mag-
nitude of the consequences of sleep loss. Studies have
documented that, while healthy women appear to have
better sleep quality than men, they report more sleep
problems, including inadequate sleep time and insom-
nia (Bixler et al. 2002, Zhang and Wing 2006). More-
over, nightmares were reported to be twice as frequent
in women (Ohayon et al. 1997). The reasons for such
discrepancies are attributed to hormonal fluctuations
over the menstrual and estrous cycles, a factor that has
been associated with sleep variations in both humans
and rats (Hachul et al. 2006, Antunes et al. 2006, 2007).
In particular, alterations in reproductive hormone
release coincidental with sleep have been suggested as
a manifestation of entrained links between CNS regula-
tion and endocrine function. Notably, our results demon-
strate that female rats submitted to PSD in the diestrous
phase (PSD-diestrous) had their estrous cycles disrupted
during the recovery period. This was evidenced by a
constant diestrus during the first week of recovery. As
for hormone alterations, progesterone concentrations
were statistically higher in PSD-diestrus compared to
the respective phase control and to PSD-proestrous
and PSD-estrous rats, while CTRL-metestrous rats had
higher levels than CTRL-proestrous and estrous groups.
In addition, the PSD-diestrous phase exhibited higher
concentrations of corticosterone and lower estrogen
levels than the respective control rats. These data in-
dicate that PSD may modulate ovarian hormone released
through alterations in hormonal-neurochemical systems.
OXIDATIVE STRESS
Sleep has been described to provide an antioxidative
function (Reimund 1994), which leads to the hypothe-
sis that sleep deprivation is associated with an accumu-
lation of free radicals. It is known that PSD induces
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a number of alterations in systemic and brain energy
metabolism (Bergmann et al. 1989, Everson et al. 1994),
as well as motor weakness, lesions in organs, and even
death (Rechtschaffen et al. 1983). It is possible that
these effects occur as a result of reactive oxygen species
(ROS) accumulation. A number of studies have reported
that ROS are involved in the pathogenesis of several
diseases and psychological stress (Halliwell and Gut-
teridge 1989).
D’Almeida and coworkers have studied the oxida-
tive stress status following PSD. First, they described a
reduction in total glutathione (GSH) levels in the whole
brain; however, a number of antioxidants were found to
be unchanged in the brain after PSD (D’Almeida et al.
1997). Furthermore, reduced GSH levels were demon-
strated in the hypothalamus and thalamus (D’Almeida
et al. 1998), suggesting that these specific brain regions
could be more susceptible to oxidative stress during PSD
(D’Almeida et al. 2000). To investigate the hypotheses
that (i) sleep involves a process of detoxification at the
cellular level (Inoué et al. 1995) and (ii) that sleep may
serve as an antioxidant function by removing free radi-
cals or ROS produced during waking (Reimund 1994),
and, considering that GSH levels were counteracted by
melatonin administration (Floreani et al. 1997), the au-
thors tested the effects of exogenous melatonin admin-
istration on the PSD-induced decrease in GSH. Twice
daily administration of melatonin during the PSD pe-
riod, and equivalent dosing in controls, resulted in sim-
ilarly lowered hypothalamic GSH levels, indicating that
the antioxidant properties of melatonin were not able to
preserve hypothalamic GSH levels after PSD, and that
exogenous melatonin may lead to decreases in hypo-
thalamic GSH levels and further the decrease induced
by PSD in this brain region (D’Almeida et al. 2000).
Reduced GSH levels, a key indicator of oxidative
stress, have been shown to precipitate apoptotic cell
death in the brain under different conditions (Tan et al.
1998). Based upon the above-described findings of
D’Almeida and colleagues, a study was performed that
showed that binding of the “peripheral-type” benzodi-
azepine ligand [3H]PK 11195 to reactive astrocytes, a
reliable and sensitive index of necrotic changes, was not
altered in 14 examined brain regions, and mRNA lev-
els of the apoptosis-related genes bcl-2 and bax in any
of 24 brain areas studied (Hipólide et al. 2002) were
likewise unchanged. These findings suggest that the
oxidative stress that develops in the brains of rats sub-
mitted to PSD does not result in cell loss.
Considering the stressful nature of the PSD
method, which is associated with the disruption of
various physiological processes, D’Almeida’s group
described that plasma homocysteine (an intermediate
amino acid in methionine-cysteine metabolism) was
reduced in PSD rats as compared with the cage group,
and did not revert to normal levels after 24 or 48h of
recovery. Decreased glutathione and increased thio-
barbituric acid reactive substance levels were observed
in PSD rats (Oliveira et al. 2002). The authors sug-
gested that the observed decreases in homocysteine
levels may represent a self-correcting response to de-
pleted glutathione in PSD rats, which would contrib-
ute to the attenuation of the deleterious effects of
PSD. Homocysteine levels were decreased in older rats
as compared to young ones; PSD did not further re-
duce the lowered levels in aged animals. Additionally,
PSD had no effect on total cholesterol or folate lev-
els, while it increased HDL, LDL, and vitamin B12, anddecreased triglyceride and VLDL levels (Andersen et
al. 2004c). Indeed, the increase in LDL levels, which
was much more pronounced than the increase in HDL,
would constitute an unfavorable factor since the LDL/
HDL ratio represents a better assessment of cardiovas-
cular disease risk than HDL cholesterol levels alone
(Lemieux et al. 2001). These results indicate that PSD
has significant but heterogeneous physiological effects
in aged rats, and it may intensify certain age-related
effects that contribute to cardiovascular disease risk
(Andersen et al. 2004c).
One of the most common sleep disorders, obstruc-
tive sleep apnea, is characterized by an airflow interrup-
tion despite persistent respiratory efforts, thus causing
chronic sleep deprivation due to the frequent awakening
at the termination of apneic episodes. As sleep depriva-
tion may aggravate hypertensive features, and since car-
diorespiratory changes are observed after PSD, Palma et
al. (2002) studied the participation of endothelin-1 in
the genesis of hypertension and heart disease by deter-
mining plasma endothelin-1/2 levels in PSD rats. The
data evidenced that PSD altered endothelin-1/2 concen-
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trations, suggesting that the increase in the endothelin
levels may be involved in the genesis of arterial hyperten-
sion and cardiorespiratory changes, which are observed
after sleep deprivation (Palma et al. 2002).
It has been proposed that both hypoxia and sleep
fragmentation are implicated in the cardiovascular risk
associated with obstructive sleep apnea. Studies have
demonstrated that hypoxia reduces delta and REM
sleep and prolongs stages 1 and 2 of NREM sleep (Bers-
senbrugge et al. 1984). However, it is not possible to
determine whether the effects of obstructive sleep ap-
nea in humans are caused by hypoxia per se or whether
they are due to the frequency of arousals induced by
breathing alterations during sleep or both (Berssenbrug-
ge et al. 1983). To address this issue, we have been
conducting studies using intermittent hypoxia in rats. As
described by Perry et al. (2007), subchronic exposure
to intermittent hypoxia (10% O2) did not affect the bio-chemical blood parameters related to cardiovascular
risk, but subchronic PSD reduced triglyceride. These
parameters remained reduced when PSD was combined
with intermittent hypoxia. Further investigation into
the association between hypoxia and sleep deprivation,
which is known as sequelae of obstructive sleep apnea,
may be useful in understanding the influence of both
factors on the cardiovascular system.
STRESS
In addition to sleep deprivation, achieved by either the
single platform method or variations, the techniques in-
duce high levels of stress and have been a subject of
debate. If sleep is essential for health and life, then sleep
deprivation is a biological stressor. Indeed, some signs of
sleep deprivation are weight loss, reduced thymus weight
(Coenen and Van Luijtelaar 1985), increased adrenal
weight (Coenen and Van Luijtelaar 1985, Suchecki and
Tufik 2000), augmented corticosterone (Suchecki and
Tufik 2000, Andersen et al. 2003c, 2004b, d, 2005a,
Hipólide et al. 2006), and ACTH levels (Andersen et
al. 2005a). Sleep deprivation produces a marked nega-
tive energy balance, indicating that hypercatabolism is a
central effect of sleep deprivation in rats (Everson 1997)
in addition to termorregulation alteration (Seabra and
Tufik 1993, Hoshino 1996). Moreover, c-fos expression
is increased in the preoptic area of cats submitted to the
flower pot technique (Ledoux et al. 1996). Increased
binding of CRF receptors in several brain areas and re-
duced hypothalamic CRF content is observed in sleep
deprived rats (Fadda and Fratta 1997). As the sleep-wake
cycle is distinctly affected by stress (Papale et al. 2005),
further research is warranted to elucidate both how sleep
is interrupted by stress and the long-term effects inflicted
by sleep deprivation, an inherent stress condition, on the
organism’s coping skills.
DEPRESSION
Since its first experimental demonstration (Pflug and
Tölle 1971), the antidepressant effect of sleep depri-
vation for one night has been widely investigated. Af-
ter many years, the procedure of sleep deprivation has
proven its efficacy for alleviating depression in approx-
imately 60% of the cases after a single session, and in
almost 90% after three sessions performed at one-week
intervals (for review see Wu and Bunney 1990, Wirz-
Justice and Van der Hoofdakker 1999). However, this
effect is normally only transient, and, in most cases,
relapse occurs after the first episode of recovery sleep
(Southmayd et al. 1990). Despite the numerous studies
of total sleep deprivation, and based on the theory that
PS pressure is increased in depressed patients (Vogel et
al. 1980), some attempts were made to evaluate the ef-
fects of selective PSD.
Apart from therapeutic PSD, the relationship be-
tween PSD effects and noradrenergic, serotonergic and
other effects of antidepressant drugs has been investi-
gated. In 1983, Tufik and Silveira-Filho demonstrated
that PSD rats were more sensitive to imipramine and
fluoxetine and also to nomifensive, which showed a bi-
phasic effect. As has been suggested, PSD may underlie
the clinical effects of antidepressants in the context of
depression (Vogel 1975). Thus, potentiation of the ther-
apeutic effects of antidepressants by PSD suggests that
the depressants in clinical, as well as in locomotor ac-
tivity (as used in this report) in rodents, share a com-
mon mechanism (Tufik and Silveira-Filho 1983). The
development of anhedonia, characterized by loss of in-
terest following rewarding stimuli, was recently stud-
ied by Pezzato et al. (unpublished data) in PSD rats
since the occurrence of a depressive like-state may be
an important factor to consider in sleep-deprived stud-
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ies. The results indicate that PSD promotes a progressive
decrease in daily sucrose intake, whereas the increase in
sucrose intake observed during the rebound period could
be attributed to a change in the strategy of coping.
The majority of investigators have concluded that
the immediate effect of a single session of sleep de-
privation in humans is not influenced by the adminis-
tration of antidepressant drugs (for review see Giedke
and Schwärzler 2002, Adrien 2002). The common neu-
robiological mechanisms affected by pharmacological
antidepressants and sleep deprivation suggest that sleep
loss in some insomniac or depressed patients might
be an endogenous compensatory process that is thera-
peutic rather than pathological. This proposal should
open up new strategies for the treatment of depression
(Adrien 2002).
CONCLUSION
Over the past few decades, a remarkable explosion of
research has allowed us to construct a much more com-
plete picture of the neurotransmitter, genetic, cellular,
neurophysiological and behavioral changes that are af-
fected by sleep deprivation.
Sleep deprivation seems to disrupt vital biological
processes necessary for cognitive function and physi-
cal health, yet the ways in which the body is compro-
mised are not fully understood. There is a pressure in
modern society to carry out an increasing variety and
number of activities during wakefulness. The expecta-
tion that these activities should be achieved tends to push
sleep into background. This trends toward sleep depri-
vation and irregular sleep-wake patterns with resultant
impaired concentration and memory reduces the quality
of life and the ability to enjoy and complete activities.
The balance may need to swing back toward awareness
that adequate and regular sleep is required to promote a
state of well-being during wakefulness. Once aware of
this relationship, it becomes the responsibility of each
individual to select his/her own combination of sleep
and wakefulness by prioritizing the opportunities that
present themselves every day.
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RESUMO
O sono ocupa cerca de um terço de nossas vidas, entretanto
seu impacto na saúde e sua influência nas condições patoló-
gicas ainda não foi completamente elucidado. A prevalência
dos distúrbios de sono é cada vez maior, sobretudo nas regiões
mais industrializadas, repercutindo diretamente no bem-estar
da população. Este artigo tem como objetivo sintetizar e atua-
lizar a literatura a respeito do método de privação de sono
paradoxal e seu panorama de conseqüências desde compor-
tamentais até genéticas em animais. Ainda, destacamos a con-
tribuição e relevância dos estudos experimentais realizados
por nosso grupo nas ultimas três décadas.
Palavras-chave: sono, privação de sono, rebote, dopamina,
ereção, corticosterona, memória.
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